- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Liberty Health Sciences announced it upgraded its US stock to the OTCQX Best Market, under the symbol LHSIF.
Liberty Health Sciences (CSE:LHS; OTCQX:LHSIF) announced it upgraded its US stock to the OTCQX Best Market, under the symbol LHSIF.
As quoted in the press release:
“Qualifying to trade on OTCQX Best Market represents an important and exciting milestone for our company as we continue our targeted U.S. expansion,” said George Scorsis, CEO and Director of Liberty. “We’re committed to offering our growing U.S. investor base an industry leading trading experience and this step helps achieve that goal.”
Liberty was sponsored for OTCQX by Sichenzia Ross Ference Kesner LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
“OTCQX companies are distinguished by their commitment to providing a superior trading and information experience for their investors. We look forward to supporting Liberty Health Sciences in the public market,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group Inc.
Click here to read the full press release.
Source: www.newswire.ca
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.